Carrum Health launched 10 years ago to develop value-based Centers of Excellence for employers, with the aim to revamp how ...
Investor's Business Daily on MSN20h
Hims Stock Jumps After Inking Deal To Sell Eli Lilly's Obesity Drug, ZepboundHims stock surged Tuesday after the compounding pharmacy said it would sell Eli Lilly's branded weight-loss drug on its ...
The company’s stock rise reflects investor optimism following the news that Hims & Hers will provide both branded versions of ...
Hims & Hers Health Inc (NYSE:HIMS) shares spiked higher in afternoon trading Tuesday after the company said it will offer Eli ...
Shares of the company were up 8.5% in afternoon trading. The telehealth firm is following its peers Teladoc and LifeMD in offering Lilly's Zepbound ahead of restrictions on selling copies known as ...
Hims shares gained as much as 14% in New York, their biggest gain since Feb. 19.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback